| 0.121 -0.083 (-40.69%) | 02-23 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 0.16  |
1-year : | 0.18 |
| Resists | First : | 0.13 |
Second : | 0.16 |
| Pivot price | 0.09 |
|||
| Supports | First : | 0.08 |
Second : | 0.05 |
| MAs | MA(5) : | 0.09 |
MA(20) : | 0.09 |
| MA(100) : | 0.19  |
MA(250) : | 0.33 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 25.7 |
D(3) : | 24.6 |
| RSI | RSI(14): 50.2 |
|||
| 52-week | High : | 0.88 | Low : | 0.03 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ GBNH ] has closed below upper band by 47.0%. Bollinger Bands are 65.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 7 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 0.11 - 0.11 | 0.11 - 0.11 |
| Low: | 0.1 - 0.1 | 0.1 - 0.1 |
| Close: | 0.1 - 0.1 | 0.1 - 0.1 |
Greenbrook TMS Inc., together with its subsidiaries, controls and operates a network of outpatient mental health services centers in the United States. Its centers specialize in the provision of transcranial magnetic stimulation (TMS) therapy, an FDA-cleared non-invasive therapy for the treatment of major depressive disorder and other mental health disorders, as well as related psychiatric services. As of December 31, 2021, the company operated 94 wholly owned and 55 TMS centers in the commonwealth of Virginia and the States of Maryland, Delaware, North Carolina, Missouri, Illinois, Ohio, Texas, Connecticut, Florida, South Carolina, Michigan, Alaska, Oregon, California, Iowa, and Massachusetts. Greenbrook TMS Inc. was founded in 2011 and is headquartered in Toronto, Canada.
Fri, 23 Feb 2024
Greenbrook TMS Shifts to OTC Markets Amidst Delisting - TipRanks.com - TipRanks
Fri, 23 Feb 2024
Greenbrook TMS to be delisted from Nasdaq on February 26 - Investing.com
Thu, 22 Feb 2024
Crude Oil Rises 1%; US Jobless Claims Fall To 201,000 - Draganfly (NASDAQ:DPRO) - Benzinga
Wed, 21 Feb 2024
Why Is Greenbrook TMS (GBNH) Stock Up 174% Today? - InvestorPlace
Fri, 05 Jan 2024
Mental Health Treatment: Compass Pathways And Greenbrook TMS Join Forces For Psilocybin Therapy Research - Markets Insider
Fri, 05 Jan 2024
Compass Pathways and Greenbrook TMS enter into three-year research collaboration agreement - GlobeNewswire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Care Facilities
|
|
| Shares Out | 46 (M) |
| Shares Float | 13 (M) |
| Held by Insiders | 47.8 (%) |
| Held by Institutions | 30.6 (%) |
| Shares Short | 114 (K) |
| Shares Short P.Month | 101 (K) |
| EPS | -2.07 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -1.3 |
| Profit Margin | -83.2 % |
| Operating Margin | -31.2 % |
| Return on Assets (ttm) | -14 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | -13.2 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 1.69 |
| EBITDA (p.s.) | -0.64 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -12 (M) |
| Levered Free Cash Flow | -10 (M) |
| PE Ratio | -0.05 |
| PEG Ratio | 0 |
| Price to Book value | -0.08 |
| Price to Sales | 0.05 |
| Price to Cash Flow | -0.4 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|